View |
|
DRP-10323-05
|
Etoricoxib
|
Restorix-90
|
90 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-inflammatory and Antirehumatic
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
23 May 2023
|
10 September 2026
|
View |
|
DRP-13364-02
|
Diphenhydramine Hydrochloride
|
Diphmax
|
50 mg/mL
|
Solution for Injection (IM/IV)
|
H1-Receptor Antagonist (Antihistamine)
|
GRAND PHARMACEUTICAL (CHINA) CO., LTD.
|
China
|
CLIDP Conversion
|
06 February 2024
|
16 October 2028
|
View |
|
DRP-6570-10
|
Cefuroxime (as sodium)
|
Retacef-750
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
NCPC Hebei Huamin Pharmaceutical Co., Ltd
|
China
|
Automatic Renewal
|
23 January 2024
|
10 March 2029
|
View |
|
DRP-6570-12
|
Cefuroxime (as sodium)
|
CEFUSAVE-750
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.
|
|
CLIDP Conversion
|
12 January 2024
|
10 March 2029
|
View |
|
DRP-7266
|
Phytomenadione
|
Phytomen
|
10 mg/mL
|
Solution for Injection (IV/IM/SC)
|
Vitamin
|
Wuhu Kangqi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 June 2021
|
18 June 2025
|
View |
|
DRP-7266-01
|
Phytomenadione
|
Dynaphyto
|
10 mg/mL
|
Solution For Injection (I.V./I.M./S.C.)
|
Vitamin
|
Wuhu Kangqi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 June 2021
|
18 June 2025
|
View |
|
DRP-7266-02
|
Phytomenadione
|
Phytolin
|
10 mg/mL
|
Solution For Injection (I.V./I.M./S.C.)
|
Vitamin
|
Wuhu Kangqi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 June 2021
|
18 June 2025
|
View |
|
DRP-7266-03
|
Phytomenadione
|
Menavit-K
|
10 mg/mL
|
Solution For Injection (I.V./I.M./S.C.)
|
Vitamin
|
Wuhu Kangqi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 June 2021
|
18 June 2025
|
View |
|
DRP-6136-05
|
Ampicillin (as sodium)
|
Bampi-1
|
1 g
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
North China Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
06 February 2024
|
13 March 2029
|
View |
|
DRP-6136-01
|
Ampicillin (as sodium)
|
Gocillin
|
1 g
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
NORTH CHINA PHARMACEUTICAL CO., LTD.
|
China
|
CLIDP Conversion
|
16 February 2024
|
13 March 2029
|
View |
|
DRP-6180-03
|
Ceftazidime (as Pentahydrate)
|
Keftam
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.
|
China
|
Automatic Renewal
|
07 February 2024
|
13 March 2029
|
View |
|
DRP-13179-01
|
Glutathione
|
None
|
600 mg
|
Lyophilized Powder for Injection (IM/IV)
|
Antidote
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
21 June 2023
|
14 November 2027
|
View |
|
DRP-14978
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazem
|
4 g/500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
Pharmax India Private Limited
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-14979
|
Bupivacaine hydrochloride in Dextrose
|
Masocaine Heavy
|
5 mg/80 mg per mL
|
Solution for Injection (Intrathecal)
|
Local Anesthetic
|
Mason Pharma
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-14977
|
Isoxsuprine hydrochloride.
|
Saphrinox
|
5 mg/mL (10 mg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
Peripheral Vasodilator
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DR-XY49013
|
Cefuroxime (as axetil)
|
Eoroxime-250
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zee Laboratories Limited
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-14962
|
Losartan Potassium
|
Saphlor 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Sapphire Lifesciences Pvt., Ltd.
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-14961
|
Losartan Potassium
|
Saphlor 100
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Sapphire Lifesciences Pvt., Ltd.
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-14973
|
Ciprofloxacin (as hydrochloride)
|
Floproxa
|
3 mg/mL (0.3% w/v)
|
Sterile Solution
(Drops)
|
Antibacterial (Fluoroquinolone)
|
Indiana Ophthalmics
|
India
|
Initial
|
05 March 2024
|
05 March 2029
|
View |
|
DRP-15006
|
Bupivacaine hydrochloride
|
B-cane Heavy
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide)
|
Aculife Healthcare Private Limited
|
India
|
Initial
|
08 March 2024
|
08 March 2029
|